ABSTRACT
Introduction
Bone substitutes are frequently used in dentistry to augment bone tissue or to fill bone defects. Among bone grafts, various types of hydroxyapatite, deproteinized bovine bone matrix and synthetic glasses have been largely tested on bone tissue engineering 1 . Due to its limited availability and morbidity, the autogenous bone graft as well as an inadequate potential osteoinductive and osteoconductive of the allograft, research has been conducted to develop new bone substitutes to improve bone healing 2 .
Bioglass is a bioactive particulate material made of granules consisting of silicon, sodium, calcium and phosphorus, able to bond to bone and connective tissue. It may allow for more rapid repair and regeneration of bone than other synthetic grafting materials by forming a layer of hydroxyl-carbonate apatite on its surface equivalent to the mineral phase of human bone. It has been used in a few experimental and clinical studies to treat different types of bone defect and it was claimed that bioglass promoted bone formation 1, 3 . 12 evaluated changes that occurred in rats with experimental endometriosis treated with copaiba oil. They observed a significant increase between the end and the initial volume the control group, whereas the group treated with copaiba oil had a marked reduction in endometrial growth.
Mesenchymal stem cells reside in many tissues
These results led the authors to conclude that copaiba oil can be an alternative potential treatment for endometriosis.
Many anti-inflammatory substances are currently used in clinical practice after bone grafting and fractures to minimize clinical postoperative symptoms, nevertheless their effect in bone tissue can minimize or delay the incorporation process and affect bone tissue repair [13] [14] [15] [16] [17] [18] . Despite its proven anti-inflammatory action, the effect of copaiba oil on bone tissue repair is not well established 20 . The aim of this experimental study was to evaluate the copaiba oil influence in experimental bone defects filled with two bone substitutes in rat´s jaw by evaluating histologically the composition of formed bone tissue.
Methods
The project was approved by Ethics Committee in the Use of Animals, State University of Para (UEPA) (Protocol 06/2013). intraperitoneally. Once animals' anesthesia was confirmed, the skin was shaved and the surgical site was disinfected. Subsequently, was performed an "U" (7X14mm) incision and a full-thickness flap was raised to expose the external side of jaw. Under continuous saline irrigation, a slowly rotating round burr was used to create circular defects 2.5mm in diameter in the region anterior to the jaw angles on right side of the jaw of each rat. (Figure 2) 
Gavage procedures
On the fifth postoperative day, the gavage was initiated and performed for seven days, once a day, with three different substances according to subgroups: Gbio-control and Gcell-control received 0.6ml/kg/day distillated water; Gbiooil and Gcell-oil received 0.6 ml/kg/day copaiba oil in natura (EMBRAPA); Gbio-melox and Gcell-melox received 0.25mg/ kg/day meloxicam (Medley ® ) diluted in distillated water 0.6ml/ kg (Table 1) . 
Study design
The bone defects were filled with either bioglass Forty days after surgical procedure the animals were submitted to euthanasia procedure by anesthetic´s overdoses.
The right side of the jaw was removed for histological analysis ( Figure 5 ). The fragments were fixed in 10% formalin for 48 hours and decalcified in 10% nitric acid. So, after included in paraffin, they were processed to obtain 5μm thick serial sections, which were made in buccolingual direction to compose histological blades.
The specimens were stained with hematoxylin/eosin and 
Statistical analysis
The non-parametric Kruskal-Wallis test was used to evaluate the statistical differences between the subgroups, followed by Dunn´s test considering a p-value less than 0.05 as significant.
The software Bioestat 5.3 ® was used for statistical analysis.
Results
During the research, just one animal died after surgical procedure. There were no other complications like dehiscence, fistulae or infection.
The osteoclasts activity was observed only in four groups, it was more evident in Gcell-oil (p=0.78), however this was not statistically significant ( Figure 6 ). Regarding the osteoblasts presence, the difference was due to Gcell-melox (p=0.009) that presented less osteoblastic activity ( Figure 7) . The inflammatory cells were present in all groups, however there was no statistical significance (p=0.52) (Figure 8 ). Bone formation was observed in all groups, just two animals showed no bone formation even after 40 days. More than 50% of bone matrix mineralization was observed in 56% (23 animals) of the analyzed areas. The bone matrix mineralization was not different between groups (p=0.60) (Figures 9 and 10 ).
Discussion
The results from the present study showed that rat jaw grafted with two different biomaterials (bioglass or adipose tissue), obtained, in the 40-day postoperative period, a larger extent of bone matrix deposition, indicating that the groups had similar amounts of mineral deposition in this period of the repair.
The two grafting materials seemed to perform in a similar way concerning their contribution to bone formation which is consistent whit other studies 1, 2, 4, 5, 20 . They appeared to be osteoconductive, leading to a mineralized bone matrix with osteoblasts and chronic inflammatory infiltrate.
Through histological evaluation regarding the quality of newly formed bone tissue and comparing the oil, control and melox groups can be inferred that copaiba oil did not interfere with bone formation. To date, just one research correlating copaiba oil to the healing of bone tissue was found. Silva et al. 20 evaluated the influence of topic and systemic administration of copaiba oil on the alveolar wound healing after tooth extraction in rats. They observed an increased bone neoformation in both groups treated with copaiba oil when compared with placebo group, however, the topic application should be carefully considered because rats treated with topic administration of copaiba oil presented ulcerations and large number of inflammatory cells 20 .
Several other substances with anti-inflammatory properties have been subject of research in this area with contradictory findings 13, 15, 18 . The studies indicates that nonsteroidal anti-inflammatory drugs (NSAIDs) with higher selectivity to COX-2 showed delayed bone healing and compromised bone density 13, 15, 18 . Even the glucocorticoids, by inhibition of COX-2 showed a reduced osteogenic differentiation and maturation 13 while non-selective or NSAIDs with low selectivity did not show changes in bone repair 17, 18 .
In the present study, meloxicam, a preferential inhibitor to COX-2, decreased osteoblasts presence when administered in the group that received adipose tissue graft (p<0.05), which probably affected the synthesis of bone matrix by mesenchymal stem cells, being consistent with studies showing that non-steroidal antiinflammatory drugs affects the quality of bone repair 13, 15 . However, there was a good mineralization of bone matrix formed after forty days in this specific group, suggesting the osteoblasts were present but could have a time-limited activity.
The anti-inflammatory activity of copaiba oil has not yet been clearly elucidated. It is believed that such activity is due to the sesquiterpenes which are known to inhibit the activity of receptor activator of nuclear factor kappa b (RANK). RANK is the receptor for RANK-Ligand (RANKL) and part of a signaling pathway that regulates osteoclast differentiation and activation. It is associated with bone remodeling and repair, immune cell function, lymph node development, thermal regulation, and mammary gland development.
Its presence on the osteoclast precursors and mature osteoclasts´ surface plays an important role in promoting the differentiation and activation of osteoclasts, leading to bone resorption 11, 12, 20 . Silva et al. 20 believe that positive influence of copaiba oil on alveolar bone formation is probably explained by the fact that the sesquiterpenes of copaiba oil inhibited the action of RANK, facilitating the alveolar bone repair.
In the present study the copaiba oil was administered by gavage and the bone formation was histologically evaluated 40 days after the procedure, these two factors could contribute to the results found. Others ways of copaiba oil administration and assessment in shortest and largest period of time, could contribute to different results of this substance influence in jaw bone repair.
Conclusion
Copaiba oil did not affect the amount of bone formation in jaw defects in rats 40 days after the procedure.
